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 One of the most common causes of death is Ischaemic heart disease (IHD). 
Clinical decisions are often made based on doctors’ intuition and experience 
rather than on the knowledge-rich data hidden in the database, which leads to 
unwanted errors and excessive medical costs that affects the quality of 
service provided to patients. On the other hand, there is lack of cardiologist 
and IHD specialist in developing countries. Therefore, the development of an 
expert system that improves the diagnostic and therapeutic decision model of 
IHD creates a universal need. The expert system is developed based on the 
cardiologist expertises in diagnosing IHD symtomps and the given 
prescriptions. This work attempts to increase the accuracy and the 
effectiveness of the expert system to treat IHD patient by leveraging deep 
neural networks and adopting deep learning strategy for Retristic Boltzman 
Machine (RBM). The deep neural network in this work has 152 neurons in 
the input layer, 52 neurons in the output layer, and 4 hidden layer. 
Experimental results show that the proposed system achieves up to 0.00974 
error level in the training sessions and average improvement of 0.7322% in 
term of accuracy compared to expert system with standard machine learning 
in the testing phase. Some results that have discrepancies are consulted to the 
cardiologist to confirm the results. 
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1. INTRODUCTION 
Ischaemic heart disease (IHD) is related to various cardiovascular circumstances or risk factors and 
consequently, treatment can be complex. Thus, “treatment deserves a comprehensive management approach, 
including pharmacotherapeutic and invasive or surgical therapies, professional lifestyle interventions based 
on behavioural models of change, with different strategies from more basic, family-based to more structured 
and complex modalities, depending on the cardiovascular risk assessment and on concomitant diseases” [1]. 
Risk factor management concentrating on monitoring related cardiovascular risk factors, covering 
psychosocial support, physical activity advice and appropriate prescription of an adherence to cardio-
protective drugs are integral to serving patients recover as normal a life as possible and advance their quality 
of life. 
IHD is one of the most common causes of death in the world. This is the reason why the 
development of a broadly accepted expert system for accurately performing diagnostic and therapeutic 
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decision model of ischaemic heart disease constitutes a general need. In addition, insufficient IHD specialist 
in developing countries especially in rural area requires a support of an expert system to help non-specialist 
to accurately diagnose and treat IHD patients. 
Physicians need a systemic approach to actual clinical problems. Such a strategy ensures the 
maximum diagnostic accuracy at minimum risk and expense to the patient. Most cardiologists pursue a line 
of questioning to establish whether the actual chest pain is typically cardiac, a typical or non-cardiac in 
origin. It is therefore important to determine the sequence of the steps in the diagnosis of IHD. Clinical 
decisions are often made based on doctors’ intuition and experience rather than on the knowledge-rich data 
hidden in the database. This practice leads to unwanted biases, errors and excessive medical costs which 
affects the quality of service provided to patients. 
Many works (such as [2-6]) have already been carried out on the development of expert systems for 
IHD diagnosis and treatement with the use of intelligent systems such as fuzzy logic, genetic algorithm and 
artificial neural network. The existing expert systems using conventional neural network face problem with 
accuracy. This work attempts to develop an intelligent engine to improve the accuracy of such expert system 
by leveraging the deep learning concept. The expert system is expected to help cardiologists as well as 
general physicians (in case the absence of the cardiologists in rural area) to accurately treat the IHD patients. 
 
 
2. RESEARCH METHOD 
This work uses the deep neural networks due to its advantace in processing inter-related string/text 
input data. 
 
2.1. Dataset 
305 Patient clinical data related to IHD are collected from a hospital in Jakarta, Indonesia. The data 
is collected as symtomps and medicine prescriptions. Each patient information has ten attributes: 
- Previous Disease Record (P1) 
- Present Disease Record (P2) 
- Personal Habit Record (P3) 
- Physical Examination Results (P4) 
- Cardio Vascular System (CVS) 
- Respiratory System (RS) 
- Per Abdomen (PA) 
- Central Nervous system (CNS) 
- Electrocardiogram (ECG) 
- Blood Investigation (BI) 
 
The details of the patient data/information are shown in Table 1 to Table 10. 
 
 
 
Table 2. Previous Disease Record (P1) 
Code Disease 
1 Hypertension 
2 Diabetes Mellitus 
3 TB 
4 Bronchial Asthma 
5 Hyperthyroidism 
6 Hypothyrodism 
7 Old IHD 
8 Nil 
9 Interstitial Lung Disease (ILD) 
10 Cerebrovascular Accident (CVA) 
11 Rheumatoid arthritis 
12 Haemorrhoids (Bledding piles) 
13 Rheumaticd heart disease 
14 Atrial Fibrilation 
15 Chronic Obstructive Pulmonary Disease 
16 Supra Ventricular Techycardia (SVT) 
17 Febroid with Menorrhagia 
18 Dilated Cardiomyopathy 
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Table 3. Present Disease Record (P2) 
Code Disease 
1 Chest pain 
2 Retrosternal pain 
3 Palpitations 
4 Breathlessness 
5 Sweating 
6 Persipiration 
7 Giddiness 
8 Nausea/ Vomitting 
9 Epigastric pain 
10 Left arm pain 
11 Syncope 
12 Unconsciousness 
13 Uneasiness/restlessness 
14 Back pain 
15 Heaviness in chest 
16 Difficulty in breathing 
17 Cough 
18 Swelling over feet 
19 Convulsion 
20 Headache 
21 Heartburn 
22 Jaw/throat pain 
23 Decrease apetite 
24 Epistaxis 
25 Haemoptysis 
26 Both shoulder pain 
27 Bleeding per rectum (PR) 
28 Haemetemesis 
29 Loose motion 
 
Table 4. Personal Habit Record (P3) 
Code Disease 
1 Smoking 
2 Tobacco 
3 Alcohol 
4 Nil 
 
 
 
Table 5. Cardio Vascular System 
Code Symptoms 
1 Hearth sounds 
2 Normal heart rate 
3 Tachycardia  
4 Bradycardia  
5 Regular heart rhythm 
6 Irregular heart rhythm 
7 Gallop sound 
8 No abnormality detected (NAD) 
 
Table 6. Respiratory System 
Code Findings 
1 Breath sounds preserved 
2 Breath sounds reduced 
3 Basal crepts 
4 Ronchi 
5 No abnormality detected (NAD) 
 
 
 
Table 7. Central Nervous System (CNS) 
Code Findings 
1 Consciousness  
2 Orientation  
3 Focal deficit 
4 Restlessness  
5 No abnormality detected (NAD) 
 
Table 8. Per Abdomen (PA) 
Code Findings  
1 Liver (hepatomegaly) 
2 Spleen (splenomegaly) 
3 Free fluid present 
4 Abdominal distension 
5 Obesity  
6 No abnormality detected (NAD) 
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Table 9. ECG 
Code Disease 
1 ST elevation 
2 Anterior wall 
3 Anteroseptal 
4 Inferior 
5 Inferoposterior 
6 Lateral 
7 Septal 
8 High lateral 
9 T wafe inversion 
10 ST depression 
11 QS complex 
12 LBBB 
13 Inferior and lateral (4&6) 
14 Atrial fibrillation 
15 RBBB 
16 VBP’s 
17 Sinus tachycardia 
18 Sinus rhythm 
19 Supraventricular tachycardia SVT 
20 Left ventricular hypertrophy (LVH) 
21 Ventricular tachycardia/ fibrillation 
 
Table 10. Blood Investigation (BI) 
Code Disease 
1 Cardiac enzymes (High) 
2 Blood sugar test normal 
3 Blood sugar test low 
4 Blood sugar test high 
5 Kidney function test deranged 
6 Lipid profile normal 
7 Lipid profile abnormal 
8 Complete blood count normal 
9 Leukocytosis 
10 Anemia 
11 Thrombocytopenia 
12 Urine routine 
13 Troponin T/I (positive) 
14 No abnormality detected (NAD) 
15 Chest X-ray (cardiomegaly) 
16 2-D-Echo RWMA 
17 2-D-Echo LV CLOT 
18 2-D-Echo LVH 
19 Hypokalemia 
20 Hyponatremia 
21 Thyroid profile (abnormal) 
22 2D-Echo – poor LVEF 
23 Hypercalemia 
24 Chest X-ray (COPD) 
 
 
 
The medicines as treatments for the IHD along with their codes (MIDs) are shown in Table 11. 
While Table 12 and Table 13 show the twenty of clinical data examples on symptoms examinations, and the 
medicines prescribed by the physician, respectively. 
 
 
Table 11. The Medicines and Their Codes 
Medicine name MID  Medicine name MID 
Fortwin Inj 27 Alprazolam 1 
Diazepam Inj 28 Amlodepine 2 
Nitroglycerin Inj 29 Aspirin 3 
Ciprofloxacin Inj 30 Atenolol 4 
Cardarone 31 Atorvastatin 5 
Dobutamine Inj 32 Clopidogrel 6 
Levolin (Nebolize) 33 DIGOXIN 7 
Methyl prednisolone 34 Diltiazem 8 
Oral Hypoglycaemics 35 Diphenylhydantoin Sodium 9 
Lactulose syrup 36 Enalapril 10 
Eltoxin 37 Furosemide 11 
Dextrose 25% Inj 38 Ethamsylate 12 
Dopamine 39 Insulin Inj 13 
Warfarin sodium 40 Iso sorbide dinitrate 14 
Iron Capsule 41 Losartan 15 
Neomercazole 42 Metoprolol 16 
Betahistine HCL 43 Nikorandil 17 
Kesol Syrup / Inj 44 Ondansetron 18 
Vit -B12 45 Paracetamol 19 
Ethamysylate 46 Perindopril 20 
Fen ofibrate 47 Ramipril 21 
Inj Calcium Gluconate 48 Trimetazidine 22 
(Glucose + Insulin ) Drip 49 Streptokinase Inj 23 
K-bind powder 50 Taxim Inj 24 
Syp.Gellusil / Mucaine gel 51 Enoxaparin Inj 25 
Sucralfate Syp 52 Rabeprazole Inj 26 
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Table 12. Examples of Symptoms Examinations of 20 Patients 
P1 P2 P3 P4 CVS RS PA CNS ECG BI 
1 15,16 4 6,9,12 8 4 6 4 10 2 
1,2 4,5 4 1,2,7,13,14,16 3,5 3 5 4 12 4 
8 13,7,5 4 1,6,12 8 4 5 4 9 14 
2 1,2,8 2 7,8,13,14 8 4 5 4 2 7 
2 1,2,13,5 4 7,10 8 4 5 4 1,3 14 
8 1,4 1 6,10 8 4 5 4 3 2 
1 15,3,4 4 6,10,12 8 4 5 4 9 14 
1,7 1,17 4 6,9 6 4 5 4 9 9 
7 18 4 3,7,9,16 3 3 1 4 11,3 14 
9,2,3 4 4 7,9,13,18 3 3,5 5 4 11,3 9,10,4 
8 1,5 4 6,10 8 4 5 4 3 9,1,2 
8 1 1 19 8 4 5 4 1,9 14,2 
1,2,6 1,5,8 4 6,10,12,14 8 4 5 4 1,2 1,4,9,10 
1,7 4,3,5,6,15 4 3,7,10,13,17,18 3 3,5 5 4 4,11 15 
7,10 19 2 6,9,14 8 4 5 3 11,4 14 
1 1 4 6,9,12 8 4 5 4 10,9 14 
1,2,7 3,5,6,7 4 6,9,12 8 4 5 4 9 3 
7 1 4 6,9,12 8 4 5 4 11,4 14 
4 2,5,6,13 4 6,10,12,17,20 8 4 5 5 1,4 4,9,16,17 
7 1,5,6,13 4 20,17,6,10,13 8 4 5 5 1,3,11,4 2,9,10,16,17 
 
 
Table 13. The Corresponding Medicine Prescriptions for the 20 Patients 
MD
1 
MD
2 
MD
3 
MD
4 
MD
5 
MD
6 
MD
7 
MD
8 
MD
9 
MD
10 
MD 
11 
MD 
12 
MD 
13 
MD 
14 
MD 
15 
MD 
16 
MD 17 
11 13 14 17 3 5 7 10 29 19 30       
14 6 5 1 25             
1 3 5 6 13 14 17 19 21 23 25 26 27 29 36   
1 3 5 6 14 17 19 21 23 25 26 27 29 36    
3 14 19 15              
25 6 3 29 5 17 1 21 16         
14 3 5 6 1 26            
29 1 3 5 25 17 16 27 24         
32 11 20 33 14             
14 11 34 3 5 33 35 24          
23 1 5 6 29 25 17 31 16 21 36       
25 1 3 5 29 17 16           
23 25 26 27 28 29 13 1 3 5 16 17 18 21 37 6 36 
11 21 29 1 3 5 17 7 28 19 15       
9 30 33 3 19             
14 1 3 5 2             
38 3 14 5 1             
25 2 3 5 6 29 17 16          
2 3 5 6 13 14 17 19 21 23 25 26 27 28 29 36  
2 3 5 6 14 16 17 19 21 25 26 27 28 29 36   
 
 
2.2. Deep neural network 
Deep Neural Learning or Deep Neural Network (DNN) is a subset of machine learning in Artificial 
Intelligence (AI) that has networks which are capable of learning unsupervised from data that is unstructured 
or unlabeled. The deep neural network consists of more than 1 layer in its hidden layer [7-10]. The DNN in 
this work, has 152 neurons in the input layer, 52 neurons in the output layer, and 4 layers in the hidden layer. 
Each attribute of patient is represented by binary numbers. The number of digit representing the attribute 
depends on the number of fields shown in Table 1 to Table 10. The number of digit of P1=18, P2=29, P3=4, 
P4=25, CVS=8, RS=5, PA=6, CNS=5, ECG=21, BI=24. Thus, the total is 152 as the number of neurons for 
the input. Digit 1 represents that the symptom exists, otherwise is 0. For example, the input for the fourth 
patient record in Table 12 is as follows. 0110111 010000000000000000 11001000000010000000000000000 
0001. 
0000001001000000000000000 00000001 00010 000010 00010  
101000000000000000000 000000000000010000000000. The output is medicine prescriptions as 
shown in Table 11. So, there are 52 neurons in the output layer. As illustration, the fourth patient’s medicines 
prescription in Table 13 is represented as:  
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1010110000000100101010101110100000010000000000000000. Figure 1 illustrates the 
architecture of the DNN. 
 
 
 
 
Figure 1. Architecture of the DNN 
 
 
2.3. The Algorithm 
This work adopts the deep learning method for Retristic Boltzman Machine (RBM) from the works 
in [6] and [7]. 250 patient’s data are used for training and the other 55 data are for testing.  The main 
aim of the RBM training algorithm is to maximize the product of probabilities assigned to some training set 
V (a matrix, each row of which is treated as a visible vector v): 
 
      
 
 ∏                (1) 
 
The algorithm optimizes the weight matrix W [6]. The algorithm performs Gibbs sampling and is 
used inside a gradient descent procedure (similar to the way backpropagation is used inside such a procedure 
when training feedforward neural networks) to compute weight update. The basic, single-step contrastive 
divergence procedure for a single sample is summarized as follows: 
a. Take a training sample v, compute the probabilities of the hidden units and sample a hidden activation 
vector h from the probability distribution. 
b. Compute the outer product of v and h and call this the positive gradient. 
c. From h, sample a reconstruction v' of the visible units, then resample the hidden activations h' from this. 
(Gibbs sampling step) 
d. Compute the outer product of v' and h' and call this the negative gradient. 
e. Let the update to the weight matrix W be the positive gradient minus the negative gradient, times some 
learning rate:  
 
    (          )        (2) 
 
f. Update the biases a and b analogously: 
 
           {\displaystyle \Delta b=\epsilon (h-h')}    (3) 
 
                   (4) 
 
2.4. Implementation 
The algorithm is implemented using a high-end PC machine with the following specifications: 
Processor name: Intel Core i7-7700, Processor speed 3.8 GHz, RAM 16 GB, Storage 2.5 TB and Windows 
10 O/S. Tensorflow utility/library is used on the Phyton platform. 
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3. RESULTS AND ANALYSIS 
3.1. Training Results 
Five (5) series of training were conducted with the same number of epochs. Figure 2 shows the 
training results. The average error is 0.009895. The training time was also recorded and in average the 
proposed system achieved a rational training time compared to the standard/conventional neural network. It 
was 15% slower. 
 
 
 
 
Figure 2. Training results 
 
 
3.2. Testing Results 
Fifty-five (55) data testing were used and some data that used during the testing. We compared the 
accuracy of the proposed expert system (using DNN) with standard/conventional Neural Network (NN). Five 
experiments are carried out and the results are shown in Figure 3. The average accuracy of the proposed 
expert system with DNN is: (99.60 +99.75+99.801+99.801+99.851)/5=99.7874%, whereas the average 
accuracy of the expert system with NN is: (99.16+99.002+99.1+ 99.002+99.012)=99.0552. Thus, the 
proposed expert system with DNN improves the accuracy with 0.7322%. 
 
 
 
 
Figure 3. Accuracy of the proposed system 
 
 
Table 14 shows the sample results of the testing that have discrepancies compared with the actual 
medicine prescriptions given by the physician. Analysis from the physician are given for some discrepancies 
of the results. For example, for patient number 4: 
- Medicine no. 16 is suggested by the system as additional prescription. It is beneficial as it reduces the 
heart rate and thereby reduces workload and improves outcome.  
- Medicine no. 19 is not given by the system. It is an antipyretic drug (to reduce fever) or an analgesic 
that if it is given, will not affect the cardiac outcome.  
- Medicine No. 28 is injectable form of medicine no. 14 which the system has already prescribed.  
- Medicine no. 36 is not given by the system. It is a laxative (Stool Softener) is given to patients who 
complain passing hard stools which cannot be judged by the system. 
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Table 14. Some Testing Results 
Patient 
# 
Ssytem’s Prescription Physician Prescription Not prescribed 
Additional 
prescription 
1 1,3,5,6,14,25 3,5,7,10,11,13,14,17,19,29,30 7,10,11,13,14,17,19, 30 1,6 
2 1,3,5,6,14,25 1,5,6,14,25 Nil 3 
3 1,3,5,6,14,25 
1,3,5,6,13,14,17,19,21, 
3,25,26,27,29,36 
13,17,19,21,23,25,26,27,29,36 Nil 
4 
1,3,5,6,14,16,17,21,23,25 
,26,27,28 
1,3,5,6,14,17,19,21,23,25,26,27,29,36 19,29,36 16 
5 1,3,5,6,14,25 3,14,15,19 15,19 1,5,6,25 
6 1,3,5,6,14,25 3,5,11,14,24,33,34,35 11,24,33,34,35 1,6,25 
7 1,3,5,6,14,25 1,3,5,6,14,26 26 25 
8 1,3,5,6,14,25 1,3,5,16,17,24,25, 27,29 16,17,24,27,29 14 
9 1,3,5,6,14,25 11,14,20,32,33 11,20,32,33 1,3,5,6,25 
10 1,3,5,6,14,25 1,3,5,6,16,17,21,25,29 16,17,21,29 Nil 
 
 
4. CONCLUSION 
A deep neural network has been used to increase the accuracy of the expert system for IHD 
treatment. The proposed expert system that uses deep neural network has improved the accuracy by 0.7322% 
compared to the expert system that uses conventional neural network. in some cases, the system suggested 
new prescriptions for some patients, however, those prescriptions do not affect the cardiatic problems, 
according the advices from the physician. On the other hand, the medicines that were prescribed by the 
physician but were not prescribed by the system do not significantly affect the IHD. In other word, it 
increases efficiency in term of cost for IHD treatment. 
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